Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylnaltrexone for opioid-induced constipation in palliative care
2012-000850-75Phase 4Active
- Sponsor
- VU University Medical Center
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylnaltrexone in opioid-induced constipation (OIC) (3 arms), sponsored by VU University Medical Center. Started May 2012; status: active.
02
Drugs
methylnaltrexone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on 2012-000850-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000850-75.